CDW Corporation
142.37USD
-2.1100 (-1.46%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.95▲ | $2.86 | 6 | 1 |
| Next quarter | $2.82▲ | $2.74 | 6 | 2 |
| Current year | $10.95▲ | $10.65 | 7 | 1 |
| Next year | $12.05▲ | $11.62 | 7 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.8 | $2.91 | +0.11 (+4.0%) |
| 2026-03-31 | $2.29 | $2.28 | -0.01 (-0.3%) |
| 2025-12-31 | $2.44 | $2.57 | +0.13 (+5.1%) |
| 2025-09-30 | $2.62 | $2.71 | +0.09 (+3.4%) |
153 ratings from 17 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Equal-Weight | $123 $150 | Sep 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $170 $171 | Aug 6, 2026 |
| Citigroup | Maintained | Neutral | $123 $145 | Jul 13, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $142 $170 | Jun 23, 2026 |
| JP Morgan | Upgraded from Neutral | Overweight | $130 | May 27, 2026 |
| Citigroup | Maintained | Neutral | $150 $123 | May 8, 2026 |
| UBS | Maintained | Buy | $162 $147 | May 7, 2026 |
| JP Morgan | Maintained | Neutral | $160 $130 | May 7, 2026 |
| Barclays | Maintained | Equal-Weight | $144 $123 | May 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $180 $160 | May 7, 2026 |
| Citigroup | Maintained | Neutral | $148 $150 | Feb 5, 2026 |
| JP Morgan | Maintained | Neutral | $170 $160 | Feb 5, 2026 |
| Barclays | Maintained | Equal-Weight | $148 $144 | Feb 5, 2026 |
| UBS | Maintained | Buy | $190 $162 | Feb 5, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $141 $142 | Feb 5, 2026 |
| Citigroup | Maintained | Neutral | $160 $148 | Jan 20, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $177 $141 | Jan 20, 2026 |
| Morgan Stanley | Maintained | Overweight | $191 $177 | Dec 17, 2025 |
| Raymond James | Upgraded from Outperform | Strong Buy | $185 | Nov 25, 2025 |
| UBS | Maintained | Buy | $200 $190 | Nov 5, 2025 |
| Barclays | Maintained | Equal-Weight | $176 $148 | Nov 5, 2025 |
| Evercore ISI Group | Maintained | Outperform | $215 $200 | Oct 20, 2025 |
| UBS | Maintained | Buy | $210 $200 | Aug 7, 2025 |
| Barclays | Maintained | Equal-Weight | $205 $176 | Aug 7, 2025 |
| JP Morgan | Maintained | Neutral | $185 $205 | Jul 17, 2025 |
150 filings from 19 insiders · 50 buy / 1 sell over 6m
Officers and directors of CDW, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| CONNELLY ELIZABETH HOfficer | Sell | 26.7k | $137.62 | $3.67M | Aug 7, 2026 |
| CONNELLY ELIZABETH HOfficer | Exercise | 26.7k | $95.57 | $2.59M | Aug 7, 2026 |
| SWEDISH JOSEPH RDirector | Grant | 208 | — | — | Jul 1, 2026 |
| NELMS DAVID WDirector | Grant | 229 | — | — | Jul 1, 2026 |
| CONNELLY ELIZABETH HOfficer | Grant | 88 | $129.30 | $11k | Jun 10, 2026 |
| FOXX ANTHONY RDirector | Grant | 32 | $129.30 | $4k | Jun 10, 2026 |
| LOCY PETER ROfficer | Grant | 18 | $129.30 | $2k | Jun 10, 2026 |
| KULEVICH FREDERICK J.Officer | Grant | 65 | $129.30 | $8k | Jun 10, 2026 |
| JONES MARC ELLISDirector | Grant | 21 | $129.30 | $3k | Jun 10, 2026 |
| GRIER KELLY J.Director | Grant | 7 | $129.30 | $1k | Jun 10, 2026 |
| SANDERSON KATHERINE ELIZABETHOfficer | Grant | 65 | $129.30 | $8k | Jun 10, 2026 |
| KUMAR MUKESHOfficer | Grant | 105 | $129.30 | $14k | Jun 10, 2026 |
| TAN HANGOfficer | Grant | 164 | $129.30 | $21k | Jun 10, 2026 |
| CLARIZIO LYNDA MDirector | Grant | 7 | $129.30 | $1k | Jun 10, 2026 |
| ADDICOTT VIRGINIA CLAIREDirector | Grant | 90 | $129.30 | $12k | Jun 10, 2026 |
| SWEDISH JOSEPH RDirector | Grant | 30 | $129.30 | $4k | Jun 10, 2026 |
| LEAHY CHRISTINE AChief Executive Officer | Grant | 298 | $129.30 | $39k | Jun 10, 2026 |
| BELL JAMES ADirector | Grant | 105 | $129.30 | $14k | Jun 10, 2026 |
| MIRALLES ALBERT JOSEPH JRChief Financial Officer | Grant | 108 | $129.30 | $14k | Jun 10, 2026 |
| NELMS DAVID WDirector | Grant | 160 | $129.30 | $21k | Jun 10, 2026 |
No analyst notes on CDW yet.
Analyst Ratings
9 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 5 | 3 | 0 | 0 | Buy2.10 |
| 1 mo ago | 2 | 5 | 3 | 0 | 0 | Buy2.10 |
| 2 mo ago | 2 | 5 | 3 | 0 | 0 | Buy2.10 |
| 3 mo ago | 2 | 5 | 3 | 0 | 0 | Buy2.10 |